New data for Novartis Lucentis confirms efficacy, safety profile of individualised treatment
Novartis will submit for regulatory approval in this indication in the EU in the third quarter of this year and in Japan by 2012…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA approves new orphan drug for chronic myelogenous leukaemia
The safety and effectiveness of Bosulif was evaluated in a single clinical trial that enrolled 546 adult patients
CDSCO draft guidelines: Industry gives its verdict
Recently, the Central Drugs Standard Control Organisation (CDSCO) called for recommendations and suggestions on its draft…
Achieving high performance in pharma through supply chain analytics
Soumendra Mohanty, Global Lead, Information Management Services, Accenture, gives an indepth idea about how stronger analytical…
AIOCD urges GoM to speed up national pharmaceutical pricing policy decision
Seeks to determine prices at which pharmaceutical companies sell essential medicines in the retail market
Merck withdraws European filing for Erbitux in NSCLC
Decision based on demand for more data from European regulatory authorities
IMCD acquires pharmaceutical business of Maxwell Pharma in Malaysia
The acquisition process will be closed on September 30, 2012
Scientists create first ever 3-D ‘pancreas in a dish’
Microscopic 3-D model will allow researchers to see how pancreatic cancer develops
Strategies for success in China outlined in new Quintiles-sponsored report by Economist Intelligence…
Local presence and proactive regulatory approaches needed
M&A or MIA?
After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: missing in action. However,…